Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jesús K. Yamamoto-Furusho"'
Publikováno v:
Gaceta Médica de México. 157
Chronic idiopathic ulcerative colitis (CIUC) is a disease with multifactorial chronic inflammation of the colonic mucosa. Its prevalence ranges from 37.5-250/100,000 in North America to 10-500/100,000 in Europe. In Mexico, there are studies that show
Autor:
Rafael Barreto Zuñiga, Braulio Martínez-Benítez, Jesús K. Yamamoto-Furusho, Gabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Angel Priego-Ranero
Publikováno v:
Immunologic Research. 69:429-435
The gene of A-kinase anchor protein 12 (AKAP12) regulates cell cycle progression, cell motility, and morphology through its multiple scaffolding domains. However, the role of AKAP12 expression in ulcerative colitis (UC) patients has not been yet desc
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 86, Iss 1, Pp 70-85 (2021)
Introduction: Inflammatory bowel disease (IBD) is a chronic and incurable entity. Therapy with anti-TNF-α agents was the first biologic therapy approved in Mexico for IBD. New biologic agents, such as vedolizumab and ustekinumab, have recently been
Autor:
A. Saez, Y. Ledesma-Osorio, T. Cortés-Espinosa, Jesús K. Yamamoto-Furusho, L. Charúa-Guindic, Francisco Bosques-Padilla, R.M. Miranda-Cordero
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 85, Iss 3, Pp 246-256 (2020)
Introduction and aims: There is no systematized information for determining/monitoring the burden of inflammatory bowel disease in Mexico. The aim of the present study was to estimate the annual burden of inflammatory bowel disease on the Mexican Nat
Autor:
K.E. Bozada-Gutiérrez, R. Barreto-Zuñiga, F. Bojalil-Romano, Jesús K. Yamamoto-Furusho, Braulio Martínez-Benítez, A. Sánchez-Rodríguez
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 84, Iss 3, Pp 317-325 (2019)
Introduction and aim: Ulcerative colitis is a chronic condition characterized by inflammation affecting the colon. To objectively and integrally measure disease activity in patients with ulcerative colitis and thus optimize pharmacologic treatment, a
Publikováno v:
Gastroenterologia y hepatologia. 44(10)
Background Inflammatory bowel disease comprises two conditions: ulcerative colitis and Crohn's disease. Inflammatory Bowel Disease Questionnaire 32 (IBDQ-32) is a specific questionnaire which has been translated from English into Spanish and validate
Publikováno v:
Journal of clinical gastroenterology. 55(7)
Goals The aim of this study was to describe mental health factors associated with the development of fatigue in inflammatory bowel disease (IBD) patients. Background IBD includes ulcerative colitis and Crohn's disease. Patients with chronic diseases
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2020 (2020)
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology & Hepatology
Background. Incidence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is increasing worldwide; nevertheless, it is still unknown if this is the case in Mexico. Thus, the aim of this study was to
Publikováno v:
Clinical Rheumatology. 37:677-682
The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the fre
Crohn’s disease (CD) and ulcerative colitis (UC) are the two major forms of inflammatory bowel disease (IBD) that can affect the rectum and result in the development of perianal disease characterized mainly by fistulas, specifically in CD patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8acd6dbff984adaf35b258052f1708c
https://doi.org/10.1016/b978-0-12-815346-8.00011-4
https://doi.org/10.1016/b978-0-12-815346-8.00011-4